A lady receives the second part of the Gam-COVID-Vac (Sputnik V) COVID-19 vaccine.
Valentin Sprinchak | TASS | Getty Images
LONDON — The European Medicines Agency has mentioned will begin assessing the Russian coronavirus jab, Sputnik V, because the bloc seems to be to hurry up its vaccination program.
“EMA will assess Sputnik V’s compliance with the usual EU standards for effectiveness, safety and quality. While EMA cannot predict the overall timelines, it should take less time than normal to evaluate an eventual application,” the regulator mentioned in an announcement on Thursday.
If the review is profitable, the Russian vaccine would nonetheless want a advertising and marketing authorization software earlier than being greenlit for administration throughout the 27 member states.
The information come after a quantity of European international locations indicated that they might begin administering Sputnik V, bypassing the regulator.
This is a breaking information story and it’s being up to date.